✦ LIBER ✦

P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients (pts) with non-small cell lung cancer (NSCLC)

✍ Scribed by Jassem, J; Jakobkiewicz, J; Jassem, E; Barski, P; Zylicz, M; Skokowski, J; Badzio, A; Kobierska, G

Book ID: 118570160
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 227 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80615-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P53 and K-ras mutations are frequent eve

P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma

✍ Jacek Jassem; Ewa Jassem; Joanna Jakóbkiewicz-Banecka; Witold Rzyman; Andrzej Ba 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

## Abstract ## BACKGROUND The objective of the current study was to determine whether tumor cells harboring __P53__ and K‐__ras__ mutations could be detected in histopathologically tumor‐free surgical margins in patients with nonsmall cell lung carcinoma who underwent complete pulmonary resection.

568 Prognostic significance of K-ras cod

568 Prognostic significance of K-ras codon 12 mutations and p53 expression in patients with resected stage I and II non-small cell lung cancer (NSCLC)

✍ Graziano, S.L.; Poiesz, B.J.; Newman, N.; Abbott, L.; Gamble, G.; Rooney, M.; Mo 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB

OP78 EGFR mutations based on circulating

OP78 EGFR mutations based on circulating free DNA (cfDNA) in the subset of Japanese patients (pts) from IPASS (IRESSA Pan ASia Study), a Phase III study of first-line gefitinib (G) vs carboplatin/paclitaxel (C/P) in clinically selected patients with advanced non-small-cell lung cancer (NSCLC)

✍ N. Yamamoto; Y. Ichinose; Y. Nishiwaki; Y. Ohe; K. Nishio; H. Jiang; E. Duffield 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB